REGAFFAIRS AI
Guide · 2026-11-07 · 4 min

REMS certification for pharmacies and prescribers explained

REMS certification depends on the drug and your role. Find the right program, complete its enrollment and training, and follow its ongoing safety checks.

REMS certification means meeting a specific FDA-approved medication safety program's requirements for your role and setting. Where certification is required, follow that program's training, enrollment and safe-use checks. There is no single credential for all REMS drugs. FDA's participant guidance explains these medication-specific duties.

REMS stands for Risk Evaluation and Mitigation Strategy. Not every REMS requires certification. Some require no pharmacist activities beyond normal dispensing. FDA decides whether a REMS is necessary and approves it. The manufacturer implements its requirements. Don't submit a universal certification application directly to FDA. See FDA's explanation of participant roles.

Find the correct REMS website and requirements

Start with the medication. Use REMS@FDA to find the current program and associated materials. FDA also directs participants to product labeling and manufacturer-maintained REMS websites for detailed instructions. Its participant guidance identifies these sources.

Then choose your role and setting. Retail and inpatient pharmacy requirements can differ. A healthcare setting may have certification duties separate from those of a prescriber. Obtain the forms and training that match your work, then follow the program's enrollment instructions. Don't assume another pharmacy's process applies to yours. FDA describes these differences by participant and setting.

Treat a training course as one possible step. Depending on the program, certification, enrollment, monitoring or evidence of safe-use conditions may also be required. FDA calls certain safeguards "elements to assure safe use," or ETASU. These are possible requirements, not a checklist for every medication. FDA explains the available REMS elements.

How a pharmacy gets REMS certified

For a pharmacy or healthcare setting, certification generally starts with an authorized representative. That person enrolls the organization, completes required training and ensures staff are trained and follow the program. Use the following steps to organize the work around the specific REMS instructions. FDA outlines the representative's responsibilities.

  1. Identify the authorized representative. Have that person review the requirements for your pharmacy or setting.
  2. Complete the required training and enrollment. Use the program's designated submission channel.
  3. Check individual staff obligations. Some REMS require each dispensing pharmacist to complete training. Pharmacists or staff may also need individual enrollment to obtain dispensing authorization.
  4. Put the required dispensing checks into your procedures. Make sure staff know which conditions must be checked before a prescription is filled or refilled.

These steps reflect FDA's general participant guidance. Organizational enrollment does not automatically satisfy every staff member's duties.

What a REMS pharmacy may need to check

Depending on the medication, the pharmacy may need to confirm prescriber certification, patient enrollment or completed laboratory testing. Other duties can include patient counseling, educational materials, a Medication Guide and supply or refill restrictions. FDA lists these possible pharmacy responsibilities.

The program may support verification through its website, a call center or an electronic pharmacy-management-system interface. If testing or monitoring is a pre-dispensing condition, verify completion before filling or refilling. A pharmacy's certification does not replace that patient-specific check. See FDA's dispensing guidance.

How prescribers complete REMS enrollment and training

Read the prescriber requirements for the medication before choosing a training course or enrollment form. Some REMS require prescriber certification or enrollment, training and a knowledge assessment. Others impose different duties. The label “REMS certified provider” must therefore be understood in the context of the particular program. FDA describes prescriber participation.

Check both the initial application and the work required during treatment. Prescriber duties can include counseling patients, documenting that counseling, enrolling patients, arranging monitoring and documenting safe-use conditions. Completing enrollment alone does not fulfill those continuing duties. FDA lists these possible prescriber requirements.

Plan required testing and documentation to avoid treatment interruptions. A clinician taking over a patient may still need to enroll in that medication's REMS. Some programs permit administrative designees, but that permission does not apply automatically to every program. FDA addresses transfers of care and designees.

Keep REMS compliance procedures current

REMS can change after initial certification. Check the specific program for renewal, retraining, representative-change procedures and recordkeeping instructions. Don't apply one program's renewal interval to another. Pharmacies subject to REMS requirements may face audits by FDA, the manufacturer or a third party acting for it. FDA explains ongoing responsibilities and audits.

Old instructions can cause unnecessary enrollment work. FDA removed the clozapine REMS effective 13 June 2025. Prescribers no longer need to enroll themselves or patients in that REMS, or submit test results to it. Pharmacies no longer need REMS enrollment to order clozapine. Pharmacists no longer need REMS eligibility verification before dispensing. FDA's removal notice sets out those changes.

But removal of that REMS did not remove clinical monitoring advice. FDA still advises clinical monitoring before and during treatment according to the prescribing information. Use the current FDA communication, rather than an old certification checklist.

RegAffairs AI provides a saved answer on REMS certification and post-enrollment duties. For enrollment forms and operational requirements, follow the medication-specific materials identified in FDA's participant guidance.

Related guides